Literature DB >> 14730552

Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy.

Hiroaki Io1, Chieko Hamada, Mitsumine Fukui, Satoshi Horikoshi, Yasuhiko Tomino.   

Abstract

Because type IV collagen is synthesized by podocytes and mesangial cells, we investigated the relationship between levels of urinary type IV collagen (uIV) and renal injuries in patients with IgA nephropathy. uIV was measured by a highly sensitive one-step sandwich enzyme immunoassay prior to renal biopsy. Patients with IgA nephropathy were classified into four grades (grade 1 = good prognosis, grade 2 = relatively good prognosis, grade 3 = relatively poor prognosis, and grade 4 = poor prognosis) by the prognostic criteria of the Ministry of Health, Labor, and Welfare of Japan. Levels of uIV in grade 4 were significantly higher than those in grades 1-3. These levels tended to increase gradually due to progression of renal injuries. The grades were further divided into two groups: group I (good or relatively good prognoses) and group II (relatively poor or poor prognoses). Patients with proteinuria of <1.0 g/day were defined as groups Ip and IIp. The levels of uIV in group II were significantly higher than those in group I, and those in group IIp were significantly higher than those in group Ip. It appears that the level of uIV can be a useful marker for detection of renal injuries in IgA nephropathy. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730552      PMCID: PMC6807931          DOI: 10.1002/jcla.10099

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  Increase of urinary type IV collagen in normoalbuminuric patients with impaired glucose tolerance.

Authors:  H Takizawa; T Satoh; A Kurusu; T Hishiki; T Shike; T Gohda; A Maeda; Y Makita; S Suzuki; M Fukui; Y Tomino
Journal:  Nephron       Date:  1998-08       Impact factor: 2.847

2.  Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro.

Authors:  B Högemann; L Balleisen; J Rauterberg; B Voss; U Gerlach
Journal:  Haemostasis       Date:  1986

3.  Polyantigenic expansion of basement membrane constituents in diabetic nephropathy.

Authors:  R J Falk; J I Scheinman; S M Mauer; A F Michael
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

Review 4.  Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining.

Authors:  E Ishikawa; M Imagawa; S Hashida; S Yoshitake; Y Hamaguchi; T Ueno
Journal:  J Immunoassay       Date:  1983

5.  Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.

Authors:  Y Hayashi; H Makino; Z Ota
Journal:  Diabet Med       Date:  1992-05       Impact factor: 4.359

6.  Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus.

Authors:  M Yagame; Y Kim; D Zhu; D Suzuki; K Eguchi; Y Nomoto; H Sakai; T Groppoli; M W Steffes; S M Mauer
Journal:  Nephron       Date:  1995       Impact factor: 2.847

7.  Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy.

Authors:  M S Razzaque; A Kumatori; T Harada; T Taguchi
Journal:  Nephron       Date:  1998-12       Impact factor: 2.847

8.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Urinary detection of type IV collagen and its increase in glomerulonephritis.

Authors:  H Makino; Y Hayashi; K Shikata; K Hirata; K Akiyama; T Ogura; K Obata; Z Ota
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1995-05

10.  More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge.

Authors:  S Hashida; M Imagawa; S Inoue; K H Ruan; E Ishikawa
Journal:  J Appl Biochem       Date:  1984 Feb-Apr
View more
  3 in total

Review 1.  Therapeutic targets for treating fibrotic kidney diseases.

Authors:  So-Young Lee; Sung I Kim; Mary E Choi
Journal:  Transl Res       Date:  2014-08-13       Impact factor: 7.012

2.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?

Authors:  Federica Genovese; Alba A Manresa; Diana Julie Leeming; Morten Asser Karsdal; Peter Boor
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-28

Review 3.  Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management.

Authors:  Haresh Selvaskandan; Sufang Shi; Sara Twaij; Chee Kay Cheung; Jonathan Barratt
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.